Further investigations need to be performed in order to ascertain the pattern of expression of Lgals3 in the different brain cell populations in MS patients and the effect of Lgals3 modulation in each of these cellular populations in disease activity and progression. Here, LGALS3 is linked to myeloid sarcoma.